AstraZenecaās rare disease drug Fasenra gets US regulatorās nod
The US Food and Drug Administration approved AstraZeneca Plcās Fasenra for treatment in adult patients with a rare inflammation of blood vessels.
Drugs
Health
Pharma
Drugs
Health
Pharma
Merck meets main goal during end-stage trial of HPV vaccine in Japan
Merck & Co., announced it has met its primary and secondary goals during the end-stage trials of its human papillomavirus (HPV) vaccine in.
Drugs
Health
Pharma
AstraZenecaās asthma drug gets regulatorās approval in China
Chinaās drug regulator, the National Medical Products Association, has approvedĀ AstraZeneca Plcās asthma drug.
Drugs
Health
Pharma
Daiichi Sankyo to pay Merck $170 million for cancer test drug rights
Daiichi Sankyo will pay Merck & Co. Inc., $170 million upfront to bag commercialization and development rights of the latterās test drug for.
Drugs
Health
Pharma
Urine tests can detect cervical cancer viruses, make screening easy
Japanese researchers have developed a non-invasive alternative to detect human papillomavirus by testing urine samples, a discovery that may transform cervical cancer screening.
Drugs
Health
Pharma
AstraZeneca, Daiichiās breast cancer drug trials show rise in survival
HQ Team June 3, 2024: An antibody-drug conjugate, jointly being developed by AstraZeneca and Daiichi Sankyo, has been shown in end-stage clinical trials.
Drugs
Health
Pharma
Eisai, Biogen to sell Alzheimerās drug in Japan starting December 20Ā
HQ Team December 13, 2023: Japanās Eisai Co., and US-based Biogen Inc., announced its Leqembi injection will be sold in Japan from Japan.
Climate
Health
Pharma
Heatwaves in Japan hit agricultural output, may opt for importsĀ
HQ Team September 25, 2023: Record-breaking heatwaves have impacted agricultural production in Japan and the East Asian nation may look at imports to.
Drugs
Health
Pharma
Japan approves Eisai Co, Biogen Incās Leqembi for AlzheimerāsĀ
HQ Team September 25, 2023: Eisai Co., and Biogen Inc., announced that their drug to treat Alzheimerās disease and cognitive impairment has been.
Drugs
Health
Pharma
Pfizerās oral capsule Litfulo to treat hair loss gets EU approval
HQ Team September 19, 2023: The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss.